Navigation Links
Frost & Sullivan Lauds U-Systems for Its Unique Technology and Strategic Excellence Paving the Way for Robust Growth
Date:8/28/2012

ape that enables a quicker, more comfortable breast exam, while improving imaging resolution and reducing artifacts. The system enables rapid review and archiving of patient exams, which optimizes the workflow of the screening process and allows the operator to select individual diagnostic planes, including a high-resolution coronal view, a feature that cannot be achieved on 2D ultrasound.

"By overcoming the ultrasound modality's limitations as an adjunctive to mammography, U-Systems has developed a technology that has the potential to emerge as a life-saving diagnostic aid that enables physicians to effectively diagnose the breast cancers missed by mammography," noted Aranibar. "Even given the recent controversies surrounding breast density and cancer risk, the company's commitment to investing in clinical research aimed at delivering this important breast cancer screening tool can not be understated."

For instance, the company completed a multi-center breast cancer screening clinical study to provide the evidence needed to support a new pre-market application (PMA) submission to the U.S. Food & Drug Administration (FDA) for use of the system in screening applications for women with dense breast tissue. A unanimous vote by the FDA's radiological devices panel recommended approval in April, paving the way for U-Systems' ABUS device to become the first and only ultrasound system to obtain FDA approval for breast cancer screening indications.

U-Systems' path to success can also be attributed to its efforts to raise awareness of healthcare professionals and patients to the issues surrounding breast density. The company's dedication and efforts have attracted more than $30 million in additional venture funding since 2007, which has enabled it to further expand investments in research and development. The company has continued to provide its customers with innovative technology upgrades and enhancements for the somo-v system.

With every su
'/>"/>

SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Frost & Sullivan Recognizes Terso Solutions, Inc. with 2012 Best Practices Award
2. Frost & Sullivan Lauds MobileHelp for Its Outstanding Products and Performance in the North American Health Technology Market
3. Frost & Sullivan Recognizes Rosetta Genomics for Its Strategic Excellence and Strong Contribution to Next-Generation Diagnostics
4. Increasing Minimal Invasive Surgeries to Boost Adoption of Hybrid Operating Rooms in Europe, Says Frost & Sullivan
5. Frost & Sullivan: Improving Economies in Indonesia and Vietnam Present Strong Growth Potential in Healthcare
6. Lower Operating Expense Augments Digital X-rays Uptake Across Industries, Finds Frost & Sullivan
7. Adoption of Prefillable Syringes Rising, Especially In High-cost Drug Applications to Contain Wastage, Notes Frost & Sullivan
8. Frost & Sullivan Recognizes Secant Medical as a Key Technology Enabler for Medical Implantable Textile Structures Design
9. Somnetics Pioneering CPAP Device Receives the 2012 North American Frost & Sullivan Award for Product Differentiation Excellence
10. Frost & Sullivan 2012 New Product Innovation in Bioanalytics Awarded to Protea Biosciences
11. Frost & Sullivan: European Bipolar Therapeutics Market Slows Down in the Short Term As Key Blockbuster Drugs Go Off Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... July 3, 2015  Obsidian HDS, the developer of ... service for the management of data on pharmaceutical and ... PharmaShine now includes the 2014 Open Payments General and ... on June 30. The data disclosed on Open Payments ... industry and providers totaling $6.49 billion and is the ...
(Date:7/2/2015)... , July 2, 2015 /PRNewswire/ - ESSA Pharma Inc. ... common shares have been approved for listing and trading on ... ESSA will begin trading on NASDAQ on July 9, ... Venture Exchange under the symbol "EPI". As a ... NASDAQ, each of the Company,s outstanding special warrants issued on ...
(Date:7/2/2015)... -- Releases of the genetically engineered Oxitec ... , , reduced the dengue mosquito population in an ... 95%, well below the modelled threshold for epidemic disease ... The journal PLOS Neglected Tropical Diseases published today the ... The results showed that in Juazeiro city, northeast ...
Breaking Medicine Technology:New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 4Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 3
... , HARBIN, China, Nov. 17 /PRNewswire-Asia-FirstCall/ ... Company") (Nasdaq: CSKI ), a,leading fully integrated pharmaceutical company in ... the third quarter,of 2009. , , Third Quarter ... to $43.2 million, -- Gross profit increased 44.8% ...
... Mass., Nov. 17 Decision Resources, one of the world,s ... finds that, driven by the continued dominance of opioids that ... cancer pain drug market will increase from $2.3 billion in ... France, Germany, Italy, Spain, the United Kingdom and Japan. , ...
Cached Medicine Technology:China Sky One Medical, Inc. Announces Record Third Quarter 2009 Results 2China Sky One Medical, Inc. Announces Record Third Quarter 2009 Results 3China Sky One Medical, Inc. Announces Record Third Quarter 2009 Results 4China Sky One Medical, Inc. Announces Record Third Quarter 2009 Results 5China Sky One Medical, Inc. Announces Record Third Quarter 2009 Results 6China Sky One Medical, Inc. Announces Record Third Quarter 2009 Results 7China Sky One Medical, Inc. Announces Record Third Quarter 2009 Results 8China Sky One Medical, Inc. Announces Record Third Quarter 2009 Results 9China Sky One Medical, Inc. Announces Record Third Quarter 2009 Results 10The Cancer Pain Drug Market, Driven by the Continued Dominance of Opioids, Will Increase From $2.3 Billion in 2008 to $3.7 Billion in 2018 2
(Date:7/3/2015)... ... July 03, 2015 , ... ... July 2nd creating a buzz of media attention. In an effort to spread ... HonestyFirstReviews.com's Tiffany Hendricks. , "These days many people are feeling overwhelmed by stress ...
(Date:7/3/2015)... ... July 03, 2015 , ... Renowned rhinoplasty surgeon and Symposium Chairman, ... Dallas Rhinoplasty Symposium . To be held from March 4th - 6th, the 2016 ... the Westin Galleria Dallas. , Designed to take participants from the basic training and ...
(Date:7/3/2015)... Orange, CT (PRWEB) , ... July 03, 2015 , ... ... at home is a good blender and easily accessible, quality ingredients. Aurora Natural is ... your smoothie for an added boost of fiber, protein, antioxidants, vitamins and minerals! , ...
(Date:7/3/2015)... ... ... " Selfie on a Stick ” was featured on NewsWatch as part ... to consumers. Amanda Forstrom, a technology expert and special reporter for NewsWatch, conducted the ... , Almost every smartphone has an incredibly powerful camera built into it. And when ...
(Date:7/2/2015)... , ... July 02, 2015 , ... sweetFrog Enterprises, LLC. ... The opening is the first sweetFrog store located in Mississippi. The premium frozen yogurt ... in 2014. , The store, located at 104 Railroad Avenue, New Albany, MS 38652, ...
Breaking Medicine News(10 mins):Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 2Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 3Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2Health News:Learn How to Take Selfies like Kendall Jenner 2Health News:sweetfrog Opens First Location in Mississippi 2
... Company to Present at 26th Annual JP Morgan ... Ocera Therapeutics, Inc., a,privately-held biopharmaceutical company focused on ... gastrointestinal and,liver diseases, announced today that the U.S. ... designation to AST-120 for the treatment of,Pouchitis., ...
... - For most people who made a New Year,s,resolution ... last until,February, but for those looking to eat healthier ... sure to boost the odds of success. What,s,more, it ... a simplified,life, the feel-good reward of home cooking and ...
... Jan. 7 Breckenridge announced today,that it has entered ... a generic tablet ANDA product. Breckenridge expects to file ... by the FDA, Helm AG will,supply and Breckenridge will ... Under terms of the agreement, Breckenridge will submit an ...
... Boston Scientific,Corporation (NYSE: BSX ) today announced that ... District Court ruling which found that the,NIR(R) stent infringed ... Johnson.,The Appeals Court also reversed the District Court,s decision ... of that claim. The Appeals,Court remanded the case back ...
... division, they activate abnormally in malignant cells , , MONDAY, Jan. ... pinpointed 480 genes that play a role in cell ... than 100 of those genes show an abnormal pattern of ... this week,s issue of the Proceedings of the National ...
... imaging developed by researchers at Duke University,s Pratt School ... better than those made with traditional ultrasound, according to ... suggests that the imaging method known as Acoustic Radiation ... for screening patients at increased risk for liver cancers, ...
Cached Medicine News:Health News:Ocera Therapeutics Receives Orphan Drug Status for AST-120 for Pouchitis 2Health News:New meal planning website launches just in time to help today's busy, health-conscious families and individuals to beat the odds when it comes to keeping their New Year's resolutions around eating healthier and getting organized 2Health News:Breckenridge Pharmaceutical Signs Long Term Agreement with Helm AG (Hamburg, Germany) 2Health News:Boston Scientific Announces Court Decision 2Health News:Team Finds 118 Genes That Might Play Role in Cancer 2Health News:High-energy ultrasound sharpens view of liver tumors 2
... A lower cost alternative to Equalizers, the patented ... between two different vessel configurations. With the push ... be quickly and easily adjusted for test tubes ... Ergonomic Design for Unparalleled Comfort Pick one ...
... Exp Expandable Tip System A lower cost ... you to perform multi-sample transfers between two different ... a knob, tip spacing can be quickly and ... or 96 well plates. Ergonomic Design for ...
... Exp Expandable Tip System A ... System allows you to perform multi-sample transfers between ... pull of a knob, tip spacing can be ... microcentrifuge tubes) or 96 well plates. Ergonomic ...
... Expandable Tip System A lower cost alternative ... to perform multi-sample transfers between two different vessel ... knob, tip spacing can be quickly and easily ... 96 well plates. Ergonomic Design for Unparalleled ...
Medicine Products: